Отправить статью
EN
Адрес для писем
220006, г. Минск, ул. Ленинградская 6, кабинет 2
Телефон: +375 17 363-88-92
Эл.почта: medjournal@bsmu.by

Факторы, влияющие на эффективность заместительной терапии метадоном

В.И. Пикиреня, А.В. Копытов УО «Белорусский государственный медицинский университет»
2018 №1 | Лекции
Аннотация
Список литературы
Скачать полнотекстовую статью
В обзоре кратко приведены доказательства высокой успешности программы заместительной терапии метадоном (ЗТМ) как метода лечения синдрома зависимости от опиоидов. Показано, что наиболее важным критерием эффективности ЗТМ является время удержания в программе. Определены социально-демографические факторы, не поддающиеся коррекции, однако позволяющие лучше прогнозировать приверженность лечению среди пациентов.
Ключевые слова:
заместительная терапия метадоном, синдром зависимости от опиоидов, эффективность заместительной терапии, организационные факторы, клинические факторы, психологические факторы
Factors, affecting the efficacy of methadone maintenance therapy

In this review there provided evidence of high effectiveness of a methadone maintenance treatment (MMT) programme as a cure for an opioid abuse syndrome. It is shown that the most important efficacy criterion of MMT is a period of patients retention in the programme. There were defined socio-demographic factors, that can't be improved, but allow the better compliance prediction among the patients.

Keywords
methadone maintenance therapy, opioid abuse syndrome, substitution therapy efficacy, institutional factors, clinical factors, psychological factors
  • 1. Винницкая А.Г., Разводовский Ю.Е., Лелевич В.В. Оценка численности инъекционных потребителей наркотиков в Беларуси с использованием метода повторного захвата // Вопросы наркологии. 2011. № 5. C. 46–50.
  • 2. Abramsohn Y. [et al.]. Sense of Coherence as a Stable Predictor for Methadone Maintenance Treatment (MMT) Outcome // Journal of Psychoactive Drugs. 2009. № 3 (41). pp. 249–253.
  • 3. Alterman A.I. [et al.]. Prediction of 7 months methadone maintenance treatment response by four measures of antisociality // Drug and Alcohol Dependence. 1998. № 3 (49). pp. 217–223.
  • 4. Amato L. [et al.]. An overview of cochrane systematic reviews of pharmacological and psychosocial treatment of opioid dependence. Geneva, 2005.
  • 5. Amsterdam J. van [et al.]. European rating of drug harms // Journal of Psychopharmacology. 2015. № 6 (26). pp. 1–6.
  • 6. Astals M. [et al.]. Impact of co-occurring psychiatric disorders on retention in a methadone maintenance program: An 18-month follow-up study // International Journal of Environmental Research and Public Health. 2009. № 11 (6). pp. 2822–2832.
  • 7. Avants S.K., Margolin A., Mckee S. A path analysis of cognitive, affective, and behavioral predictors of treatment response in a methadone maintenance program. // Journal of substance abuse. 2000. № 3 (11). pp. 215–30.
  • 8. Ball J.C. [et al.]. Reducing the Risk of AIDS Through Methadone Maintenance Treatment // Journal of Health and Social Behavior. 1988. № 3 (29). p. 214.
  • 9. Ball J.C., Ross A. The Effectiveness of Methadone Maintenance Treatment / J.C. Ball, A. Ross, New York, NY: Springer New York, 1991.
  • 10. Bao Y.-P. [et al.]. A meta-analysis of retention in methadone maintenance by dose and dosing strategy. // The American journal of drug and alcohol abuse. 2009. № 1 (35). pp. 28–33.
  • 11. Beardsley K. [et al.]. Distance traveled to outpatient drug treatment and client retention. // Journal of substance abuse treatment. 2003. № 4 (25). pp. 279–85.
  • 12. Caplehorn J.R. [et al.]. Retention in methadone maintenance and heroin addicts’ risk of death. // Addiction (Abingdon, England). 1994. № 2 (89). pp. 203–9.
  • 13. Craig R.J., Olson R.E. Predicting Methadone Maintenance Treatment Outcomes Using the Addiction Severity Index and the MMPI‐2 Content Scales (Negative Treatment Indicators and Cynism Scales) // The American Journal of Drug and Alcohol Abuse. 2004. № 4 (30). pp. 823–839.
  • 14. D’Ippoliti D. [et al.]. Retention in treatment of heroin users in Italy: The role of treatment type and of methadone maintenance dosage // Drug and Alcohol Dependence. 1998. № 2 (52). pp. 167–171.
  • 15. Darke S. [et al.]. Cognitive impairment among methadone maintenance patients. // Addiction (Abingdon, England). 2000. № 5 (95). pp. 687–95.
  • 16. Deck D., Carlson M.J. Retention in publicly funded methadone maintenance treatment in two western states // The Journal of Behavioral Health Services & Research. 2005. № 1 (32). pp. 43–60.
  • 17. DiClemente C.C. [et al.]. Psychotherapy and motivational enhancement. // Recent developments in alcoholism : an official publication of the American Medical Society on Alcoholism, the Research Society on Alcoholism, and the National Council on Alcoholism. 2003. (16). pp. 115–32.
  • 18. Du, C., Liu, Y. J., Xiong, X. Y., Cheng, Y. H., Lu, H. Y., Liu G.W. Qualitative study of associated factors for compliance to methadone maintenance treatment in Beijing // Chinese Journal of Drug Dependence. 2009. (18). pp. 413–419.
  • 19. Fan C.-Y. [et al.]. Prevalence of psychiatric disorders among heroin users who received methadone maintenance therapy in Taiwan // The American Journal on Addictions. 2014. № 3 (23). pp. 249–256.
  • 20. Fernández Miranda J. [et al.]. Influence of psychiatric disorders in the effectiveness of a long-term methadone maintenance treatment. // Actas espanolas de psiquiatria. № 4 (29). pp. 228–32.
  • 21. Fletcher B.W., Battjes R.J. Introduction to the special issue: treatment process in DATOS. // Drug and alcohol dependence. 1999. № 2 (57). pp. 81–7.
  • 22. Fouladi S. [et al.]. Evaluation of Emotional Self-Awareness and Impulse Control in Drug-Dependent Individuals With and Without Borderline Personality Characteristics Undergoing Methadone Maintenance Treatment (MMT) // International Journal of High Risk Behaviors and Addiction. 2016. № 1 (6).
  • 23. Gerra G. [et al.]. Long-term methadone maintenance effectiveness: psychosocial and pharmacological variables. // Journal of substance abuse treatment. 2003. № 1 (25). pp. 1–8.
  • 24. Gerra G. [et al.]. Sexual Dysfunction in Men Receiving Methadone Maintenance Treatment: Clinical History and Psychobiological Correlates // European Addiction Research. 2015. № 3 (22). pp. 163–175.
  • 25. Gibson A. [et al.]. Exposure to opioid maintenance treatment reduces long-term mortality. // Addiction (Abingdon, England). 2008. № 3 (103). pp. 462–8.
  • 26. Graziani M., Nisticò R. Gender differences in pharmacokinetics and pharmacodynamics of methadone substitution therapy. // Frontiers in pharmacology. 2015. (6). pp. 122.
  • 27. Greenfield L. [et al.]. Patient retention in mobile and fixed-site methadone maintenance treatment. // Drug and alcohol dependence. 1996. № 2 (42). pp. 125–31.
  • 28. Hartel D.M., Schoenbaum E.E. Methadone treatment protects against HIV infection: two decades of experience in the Bronx, New York City. // Public health reports (Washington, D.C. : 1974). 1998. (113 Suppl). pp. 107–15.
  • 29. Huong A. Quality of life assessment of opioid substance abusers on methadone maintenance therapy (MMT) in University Malaya Medical Centre // ASEAN Journal. 2009. №10 June. pp. 1–11.
  • 30. Joe G.W., Simpson D.D., Hubbard R.L. Treatment predictors of tenure in methadone maintenance // Journal of Substance Abuse. 1991. № 1 (3). C. 73–84.
  • 31. Magura S., Rosenblum A. Leaving methadone treatment: lessons learned, lessons forgotten, lessons ignored. // The Mount Sinai journal of medicine, New York. 2001. № 1 (68). C. 62–74.
  • 32. Mancino M. [и др.]. Predictors of Attrition from a National Sample of Methadone Maintenance Patients // The American Journal of Drug and Alcohol Abuse. 2010. № 3 (36). C. 155–160.
  • 33. Marsch L.A. The efficacy of methadone maintenance interventions in reducing illicit opiate use, HIV risk behavior and criminality: a meta-analysis // Addiction. 1998. № January 1997 (93). C. 515–532.
  • 34. Meng J., Burris S. The role of the Chinese police in methadone maintenance therapy: A literature review // International Journal of Drug Policy. 2013. № 6 (24). C. e25–e34.
  • 35. Naji L. [и др.]. A Prospective Study to Investigate Predictors of Relapse among Patients with Opioid Use Disorder Treated with Methadone. // Substance abuse : research and treatment. 2016. № April (10). C. 9–18.
  • 36. Parrino M.W. The Renaissance of Methadone Treatment in America // Journal of Maintenance in the Addictions. 2002. № 1–2 (2). C. 5–17.
  • 37. Peles E., Schreiber S., Adelson M. Variables associated with perceived sleep disorders in methadone maintenance treatment (MMT) patients // Drug and Alcohol Dependence. 2006. № 2 (82). C. 103–110.
  • 38. Peles E., Schreiber S., Adelson M. Trends in substance abuse and infectious disease over 20 years in a large methadone maintenance treatment (MMT) clinic in Israel. // Substance abuse : official publication of the Association for Medical Education and Research in Substance Abuse. 2014. № April 2014. C. 37–41.
  • 39. Prosser J. [и др.]. Neuropsychological functioning in opiate-dependent subjects receiving and following methadone maintenance treatment. // Drug and alcohol dependence. 2006. № 3 (84). C. 240–7.
  • 40. Rapeli P. [и др.]. Cognitive functioning in opioid-dependent patients treated with buprenorphine, methadone, and other psychoactive medications: stability and correlates // BMC Clinical Pharmacology. 2011. № 1 (11). C. 13.
  • 41. RIO M. DEL, MINO A., PERNEGER T. V. Predictors of patient retention in a newly established methadone maintenance treatment programme // Addiction. 1997. № 10 (92). C. 1353–1360.
  • 42. Rotheram-Fuller E. [и др.]. Impaired performance in a test of decision-making by opiate-dependent tobacco smokers // Drug and Alcohol Dependence. 2004. № 1 (73). C. 79–86.
  • 43. Sarasvita R. [и др.]. Predictive factors for treatment retention in methadone programs in Indonesia. // Journal of substance abuse treatment. 2012. № 3 (42). C. 239–46.
  • 44. Saxon A.J. [и др.]. Pre-treatment characteristics, program philosophy and level of ancillary services as predictors of methadone maintenance treatment outcome. // Addiction (Abingdon, England). 1996. № 8 (91). C. 1197–209.
  • 45. Teplin D. [и др.]. A psychometric study of the prevalence of DSM-IV personality disorders among office-based methadone maintenance patients. // The American journal of drug and alcohol abuse. 2004. № 3 (30). C. 515–524.
  • 46. Trajanovska A.S. [и др.]. Sexual dysfunction as a side effect of hyperprolactinemia in methadone maintenance therapy. // Medical archives (Sarajevo, Bosnia and Herzegovina). 2013. № 1 (67). C. 48–50.
  • 47. Ward J. [и др.]. The effectiveness and safety of methadone maintenance // Addiction. 1996. № 11 (91). C. 1727–1729.
  • 48. Yee A. [и др.]. The Prevalence of Sexual Dysfunction among Male Patients on Methadone and Buprenorphine Treatments: A Meta-Analysis Study // The Journal of Sexual Medicine. 2014. № 1 (11). C. 22–32.
  • 49. Zhou K., Zhuang G. Retention in methadone maintenance treatment in mainland China, 2004–2012: A literature review // Addictive Behaviors. 2014. № 1 (39). C. 22–29. Поступила 08.09.2017 г.